Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Needham

AMD To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

FuboTV Seen As Inexpensive Bet On US Streaming Trends: Analyst

FuboTV (NYSE:FUBO) beat expectations in the third quarter on solid subscriber momentum and a return to positive adjusted EBITDA, but the stock weakened as price-sensitive growth pressured ARPU and raised concerns over 2026 forecasts following its Hulu + Live TV merger.

Benzinga

Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Coinbase Jumps On Big Q3 Beat As Analysts Back 'Everything Exchange' Push

Shares of Coinbase Global Inc. (NASDAQ:COIN) were trading higher on Friday after the company reported upbeat third-quarter results a day earlier.

Benzinga

Roblox's Strong Results Impress Wall Street, But Cautious 2026 Outlook Creates Uncertainty

Roblox Corp's (NYSE:RBLX) upbeat quarterly results reignited optimism about its growth potential, partially offset by management's cautious tone on 2026. However, the company's surging user-generated content and rapid adoption of AI-driven tools continue to intrigue investors.

Benzinga

Apple To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Meta Stock Has 'Meaningful Runway Ahead': Aggressive AI Investing Opens Up 'New Opportunities'

Meta Platforms (NASDAQ:META) raised its CapEx spending outlook after third-quarter financial results. Analysts are mixed on how the spending will help the company in the short- and long-term.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Google's Q3 Sends Stock To New Highs, Analysts Say 'AI Momentum Is Nanobananas'

Google parent company Alphabet, Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) has Wall Street buzzing as its Q3 results shattered expectations and officially marked the company's first quarter clearing $100 billion in revenue.

Benzinga

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Wayfair Shares Hold Steady On Growth Momentum

Wayfair Inc. (NYSE:W) shares were little changed on Wednesday after posting a third-quarter beat, with revenue up 8.1% and adjusted EPS topping expectations.

Benzinga

Nvidia To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Cadence Design Systems Outperforms Q3 Expectations Driven By Hardware, China

Shares of Cadence Design Systems Inc (NASDAQ:CDNS) remain under pressure on Tuesday, despite the company’s upbeat third-quarter results.

Benzinga

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

North Carolina Wants to ‘Lead the Nation’ in Psychedelics. Here’s 1 ‘Strong Buy’ Stock to Buy Now.

As policy meets potential in North Carolina, Atai Life Sciences could be a solid portfolio addition now.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Intel Returns To Profitability On Stronger AI-Driven Demand, These Analysts Raise Price Targets

Shares of Intel Corp (NASDAQ:INTC) climbed in early trading on Friday, after the company reported upbeat third-quarter results.

Benzinga

Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst

On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion.

Benzinga

Tesla Stock Has 'Limited Valuation Support': Analysts See Near-Term Risks After Q3 Results

Tesla Inc. (NASDAQ:TSLA) analysts see near-term risks and pressure for the stock after mixed third-quarter results and new updates on product launch timelines.

Benzinga

Salesforce Targets $60 Billion Revenue By 2030: Why Analysts See Room For Margin Expansion

Salesforce Inc (NYSE:CRM) shares rallied in early trading on Thursday, after the company set a revenue target of $60 billion for fiscal 2030.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

This Analyst Nearly Doubled His Price Target on 1 Data Center Stock. Should You Buy It Now?

Applied Digital stock jumped 27% after a Needham analyst nearly doubled his price target on strong Q1 results, but it's now trading well above the consensus target, suggesting optimism is high and future gains may be modest.

Benzinga

Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression

Needham initiated coverage on Mind Medicine Inc. (NASDAQ:MNMD), or MindMed, on Monday. The late-stage clinical biopharmaceutical company is developing novel product candidates to treat brain health disorders.

Benzinga

Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside

Needham on Monday initiated coverage on Atai Life Sciences NV (NASDAQ:ATAI), a clinical-stage biopharmaceutical company focused on developing treatments for mental health.

Benzinga

Depression-Focused GH Research Shares Could See Significant Upside: Analyst

Needham initiated coverage on Monday for GH Research PLC (NASDAQ:GHRS), citing the company’s lead drug candidate, GH-001, which had demonstrated impressive efficacy in Phase 2 versus competition.

Benzinga

Bitcoin Miner CleanSpark To Begin Building HPC Pipeline, Analyst Raises Price Target

Bitcoin mining company CleanSpark Inc (NASDAQ:CLSK) seems "serious" about building an HPC (high-performance computing) pipeline, according to Needham.

Benzinga

Levi Strauss Stock Tanking After Q3 Is Buying Opportunity, Says Analyst

Levi Strauss Co (NYSE:LEVI) shares tanked in early trading on Friday, even after the company reported upbeat third-quarter earnings.

Benzinga

Why This Applied Digital Analyst Doubles Price Target

After Applied Digital Corp (NASDAQ:APLD) reported stronger-than-expected quarterly revenues on after the market closed on Thursday, the focus has shifted to Polaris Forge 2 (PF-2), according to Needham.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations